Last updated: January 23, 2024
Sponsor: University of California, San Francisco
Overall Status: Completed
Phase
N/A
Condition
Atopic Dermatitis
Allergy
Eczema (Atopic Dermatitis)
Treatment
SkinTracker Mobile App
Clinical Study ID
NCT04404075
19-28676
Ages > 13 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Ability to provide written informed consent and comply with the protocol.
- At least 13 years of age.
- Diagnosis of atopic dermatitis by dermatologist for at least 6 months.
- Physical exam within clinically acceptable limits.
- Own or have access to a mobile device that is compatible with study mobile applicationSkinTracker.
Exclusion
Exclusion Criteria:
- Subject is unable to provide written informed consent or comply with the protocol.
- Unable to input data into SkinTracker mobile app.
- Subject is younger than 13 years of age.
- Serious known infection.
- History of immunosuppression (including human immunodeficiency virus (HIV)).
- History of malignancy within 5 years prior to screening visit, except completelytreated in situ carcinoma of the cervix, completely treated and resolvednon-metastatic squamous or basal cell carcinoma of the skin.
- Severe concomitant illness.
- Physical exam not within clinically acceptable limits.
- Subjects possess other diagnoses that, in the investigator's opinion, preclude him/herfrom safely participating in this study or interfere
Study Design
Total Participants: 11
Treatment Group(s): 1
Primary Treatment: SkinTracker Mobile App
Phase:
Study Start date:
April 25, 2022
Estimated Completion Date:
May 12, 2023
Study Description
Connect with a study center
UCSF Psoriasis and Skin Treatment Center
San Francisco, California 94118
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.